News + Filings Holdings
All
13F
13D/G
Other
|
|
BAM Opportunity Fund, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2011 |
SC 13G
| MELA SCIENCES, INC. reports a 6% stake in MELA Sciences, Inc. |
| 10/13/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/27/2010 |
SC 13G
| MELA SCIENCES, INC. reports a 5.1% stake in MELA Sciences, Inc. |
| 09/07/2010 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 5.4% stake in Boise Inc. |
| 11/30/2009 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/27/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 5.2% stake in AMAG Pharmaceuticals, Inc. |
| 10/26/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 8% stake in Evergreen Energy Inc. |
| 10/22/2009 |
SC 13G
| PONIARD PHARMACEUTICALS, INC. reports a 5% stake in Poniard Pharmaceuticals, Inc. |
| 10/21/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 6.5% stake in Medivation, Inc. |
| 09/15/2009 |
SC 13G
| DARA BioSciences, Inc. reports a 9.8% stake in DARA BioSciences, Inc. |
| 09/15/2009 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/17/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 7.6% stake in BioSante Pharmaceuticals, Inc. |
| 08/17/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 9.9% stake in Palatin Technologies, Inc. |
| 07/22/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 6.7% stake in OXiGENE, Inc. |
| 07/21/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 5.1% stake in Vanda Pharmaceuticals Inc. |
| 07/21/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
| 06/01/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 9.8% stake in Genvec, Inc. |
| 05/15/2009 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 5.9% stake in Oculus Innovative Sciences, Inc. |
| 05/12/2008 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
| 04/29/2008 |
SC 13G
| BAM Opportunity Fund, L.P. reports a 9.4% stake in ANTIGENICS INC. |
|
|